Baxalta

Introduction to the GAMMAGARD Clinical Study in MMN: Study Methods

      

This module covers the inclusion criteria and design of the GAMMAGARD LIQUID MMN trial. It identifies and describes the efficacy, safety, and tolerability endpoints for the trial, and describes the patient enrollment, discontinuation, and completion rates.

Software Skills: Articulate Storyline, Adobe Photoshop, Illustrator